An update on probiotic bifidobacteria

Lactic Acid Bacteria Microbiological and Functional Aspects, Third Edition: Revised and Expanded

Volumn , Issue , 2004, Pages 125-157

  Crittenden, Ross ^a  

^a CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889325373     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (198)

1. Mitsuoka, T. Recent trends in research on intestinal flora. Bifidobacteria Microflora 1982, 1, 3–24.
2. Benno, Y.; Sawada, K.; Mitsuoka, T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol. Immunol. 1984, 28, 975–986.
3. Balmer, S.E.; Wharton, B.A. Diet and faecal flora in the newborn: breast milk and infant formula. Arch. Dis. Child. 1990, 64, 1672–1677.
4. Sakata, S.; Kitahara, M.; Sakamoto, M.; Hayashi, H.; Fukuyama, M.; Benno, Y. Unification of Bifidobacterium infantis and Bifidobacterium suis as Bifidobacterium longum. Int. J. Syst. Evol. Microbiol. 2002, 52, 1945–1951.
5. Cai, Y.M.; Matsumoto, M.; Benno, Y. Bifidobacterium lactis Meile et al. 1997 is a subjective synonym of Bifidobacterium animalis (Mitsuoka 1969) Scardovi and Trovatelli 1974. Microbiol. Immunol. 2000, 44, 815–820.
6. Jian, W.Y.; Dong, X.Z. Transfer of Bifidobacterium incipinatum and Bifidobacterium denticolens to Scardovia inopinata gen. nov., comb. nov., and Parascardovia denticolens gen. nov., comb. nov., respectively. Int. J. Syst. Evol. Microbiol. 2002, 52, 809–812.
7. Dong, X.Z.; Xin, Y.H.; Jian, W.Y.; Liu, X.L.; Ling, D.W. Bifidobacterium thermacidophilum sp nov., isolated from an anaerobic digester. Int. J. Syst. Evol. Microbiol. 2000, 50, 119–125.
8. O’brien, J.; Crittenden, R.; Ouwerhand, A.C.; Salminen, S. Safety evaluation of probiotics. Trends Food Sci. Technol. 1999, 10, 418–424.
9. Klein, G.; Pack, A.; Bonaparte, C.; Reuter, G. Taxonomy and physiology of probiotic lactic acid bacteria. Int. J. Food Microbiol. 1998, 41, 103–125.
10. Hamilton-Miller, J.M.; Shah, S.; Winkler, J.T. Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr. 1999, 2, 223–229.
11. Fasoli, S.; Marzotto, M.; Rizzotti, L.; Rossi, F.; Dellaglio, F.; Torriani, S. Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int. J. Food Microbiol. 2003, 82, 59–70.
12. Hamilton-Miller, J.M.T.; Shah, S. Deficiencies in microbiological quality and labelling of probiotic supplements. Int. J. Food Microbiol. 2002, 72, 175–176.
13. Weese, J.S. Microbiologic evaluation of commercial probiotics. J. Am. Vet. Med. Assoc. 2002, 220, 794–797.
14. Weese, J.S.; Arroyo, L. Bacteriological evaluation of dog and cat diets that claim to contain probiotics. Can. Vet. J. 2003, 44, 212–216.
15. Ventura, M.; Zink, R. Rapid identification, differentiation, and proposed new taxonomic classification of Bifidobacterium lactis. Appl. Environ. Microbiol. 2002, 68, 6429–6434.
16. Mogensen, G.; Salminen, S.; O’Brien, J.; Ouwehand, A.; Holzapfel, W.; Shortt, C.; Fondén, R.; Miller, G.D.; Donohue, D.; Playne, M.; Crittenden, R.; Bianchi-Salvadori, B.; Zink, R. Inventory of microorganisms with a documented history in food. Bull. IDF 2002, 377, 10–19.
17. Isolauri, E.; Arvola, T.; Sutas, Y.; Moilanen, E.; Salminen, S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 2000, 30, 1604–1610.
18. Mattila-Sandholm, T.; Blum, S.; Collins, J.K.; Crittenden, R.; de Vos, W.; Dunne, C.; Fondén, R.; Grenov, B.; Isolauri, E.; Kiely, B.; Marteau, P.; Morelli, L.; Ouwehand, A.; Reniero, R.; Saarela, M.; Salminen, S.; Saxelin, M.; Schiffrin, E.; Shanahan, F.; Vaughan, E.; von Wright, A. Probiotics: towards demonstrating efficacy. Trends Food Sci. Technol. 1999, 10, 393–399.
19. Arunachalam, K.; Gill, H.S.; Chandra, R.K. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur. J. Clin. Nutr. 2000, 54, 263–267.
20. Chiang, B.L.; Sheih, Y.H.; Wang, L.H.; Liao, C.K.; Gill, H.S. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur. J. Clin. Nutr. 2000, 54, 849–855.
21. Gill, H.S.; Rutherfurd, K.J.; Cross, M.L. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J. Clin. Immunol. 2001, 21, 264–271.
22. Gill, H.S.; Rutherfurd, K.J.; Cross, M.L.; Gopal, P.K. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 2001, 74, 833–839.
23. Venturi, A.; Gionchetti, P.; Rizzello, F.; Johansson, R.; Zucconi, E.; Brigidi, P.; Matteuzzi, D.; Campieri, M. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther. 1999, 13, 1103–1108.
24. Gionchetti, P.; Rizzello, F.; Venturi, A.; Brigidi, P.; Matteuzzi, D.; Bazzocchi, G.; Poggioli, G.; Miglioli, M.; Campieri, M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119, 305–309.
25. von Wright, A.; Vilpponen-Salmela, T.; Llopis, M.P.; Collins, K.; Kiely, B.; Shanahan, F.; Dunne, C. The survival and colonic adhesion of Bifidobacterium infantis in patients with ulcerative colitis. Int. Dairy J. 2002, 12, 197–200.
26. Ishikawa, H.; Akedo, I.; Umesaki, Y.; Tanaka, R.; Imaoka, A.; Otani, T. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J. Am. College Nutr. 2003, 22, 56–63.
27. Mogensen, G.; Salminen, S.; O’Brien, J.; Ouwehand, A.; Holzapfel, W.; Shortt, C.; Fondén, R.; Miller, G.D.; Donohue, D.; Playne, M.; Crittenden, R.; Bianchi-Salvadori, B.; Zink, R. Food microorganisms—health benefits, safety evaluation and strains with documented history of use in foods. Bull. IDF 2002, 377, 4–9.
28. Becker, M.R.; Paster, B.J.; Leys, E.J.; Moeschberger, M.L.; Kenyon, S.G.; Galvin, J.L.; Boches, S.K.; Dewhirst, F.E.; Griffen, A.L. Molecular analysis of bacterial species associated with childhood caries. J. Clin. Microbiol. 2002, 40, 1001–1009.
29. Salminen, S.; von Wright, A.; Morelli, L.; Marteau, P.; Brassart, D.; de Vos, W.M.; Fondén, R.; Saxelin, M.; Collins, K.; Mogensen, G.; Birkeland, S.E.; Mattila-Sandholm, T. Demonstration of safety of probiotics: a review. Int. J. Food Microbiol. 1999, 44, 93–106.
30. Ouwehand, A.C.; Salminen, S.J. The health effects of cultured milk products with viable and non-viable bacteria. Int. Dairy J. 1998, 8, 749–758.
31. Ouwehand, A.C.; Kirjavainen, P.V.; Shortt, C.; Salminen, S. Probiotics: mechanisms and established effects. Int. Dairy J. 1999, 9, 43–52.
32. Shah, N.P.; Ravula, R.R. Influence of water activity on fermentation, organic acids production and viability of yogurt and probiotic bacteria. Aust. J. Dairy Technol. 2000, 55, 127–131.
33. De Vuyst, L. Technology aspects related to the application of functional starter cultures. Food Technol. Biotechnol. 2000, 38,105–112.
34. Vinderola, C.G.; Mocchiutti, P.; Reinheimer, J.A. Interactions among lactic acid starter and probiotic bacteria used for fermented dairy products. J. Dairy Sci. 2002, 85, 721–729.
35. Vinderola, C.G.; Costa, G.A.; Regenhardt, S.; Reinheimer, J.A. Influence of compounds associated with fermented dairy products on the growth of lactic acid starter and probiotic bacteria. Int. Dairy J. 2002, 12, 579–589.
36. Baron, M.; Roy, D.; Vuillemard, J.C. Biochemical characteristics of fermented milk produced by mixed-cultures of lactic starters and bifidobacteria. Lait. 2000, 80, 465–478.
37. Miller, C.W.; Nguyen, M.H.; Rooney, M.; Kailasapathy, K. The influence of packaging materials on the dissolved oxygen content of probiotic yoghurt. Packag. Technol. Sci. 2002, 15, 133–138.
38. Beerens, H.; Gavini, F.; Neut, C. Effect of exposure to air on 84 strains of bifidobacteria. Anaerobe 2000, 6, 65–67.
39. Crittenden, R.G.; Morris, L.F.; Harvey, M.L.; Tran, L.T.; Mitchell, H.L.; Playne, M.J. Selection of a Bifidobacterium strain to complement resistant starch in a synbiotic yohgurt. J. Appl. Microbiol. 2001, 90, 268–278.
40. Vandenplas, Y. Oligosaccharides in infant formula. Br. J. Nutr. 2002, 87, S293–S296.
41. Mountzouris, K.C.; McCartney, A.L.; Gibson, G.R. Intestinal microflora of human infants and current trends for its nutritional modulation. Br. J. Nutr. 2002, 87, 405–420.
42. Bozanic, R.; Tratnik, L. Quality of cow’s and goat’s fermented bifido milk during storage. Food Technol. Biotechnol. 2001, 39, 109–114.
43. Al-Saleh, A.A. Growth of Bifidobacterium longum NCFB 2716 in ultrafiltered skimmed milk retentates from cow, camel and sheep. Aust. J. Dairy Technol. 2000, 55, 145–147.
44. Chou, C.C.; Hou, J.W. Growth of bifidobacteria in soymilk and their survival in the fermented soymilk drink during storage. Int. J. Food Microbiol. 2000, 56, 113–121.
45. Tsangalis, D.; Ashton, J.F.; McGill, A.E.J.; Shah, N.P. Enzymic transformation of isoflavone phytoestrogens in soymilk by beta-glucosidase-producing bifidobacteria. J. Food. Sci. 2002, 67, 3104–3113.
46. Shimakawa, Y.; Matsubara, S.; Yuki, N.; Ikeda, M.; Ishikawa, F. Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food. Int. J. Food Microbiol. 2003, 81, 131–136.
47. Bekers, M.; Marauska, M.; Laukevics, J.; Grube, M.; Vigants, A.; Karklina, D.; Skudra, L.; Viesturs, U. Oats and fat-free milk based functional food product. Food Biotechnol. 2001, 15, 1–12.
48. Martensson, Oste B.; Holst, O. The effect of yoghurt culture on the survival of probiotic bacteria in oat-based, non-dairy products. Food Res. Int. 2002, 35, 775–784.
49. Daigle, A.; Roy, D.; Belanger, G.; Vuillemard, J.C. Production of probiotic cheese (Cheddarlike cheese) using enriched cream fermented by Bifidobacterium infantis. J. Dairy Sci. 1999, 82, 1081–1091.
50. Vinderola, C.G.; Prosello, W.; Ghiberto, D.; Reinheimer, J.A. Viability of probiotic (Bifidobacterium, Lactobacillus acidophilus and Lactobacillus casei) and nonprobiotic microflora in Argentinian Fresco cheese. J. Dairy Sci. 2000, 83, 1905–1911.
51. Ryhanen, E.L.; Pihlanto-Leppala, A.; Pahkala, E. A new type of ripened, low-fat cheese with bioactive properties. Int. Dairy J. 2001, 11, 441–447.
52. McBrearty, S.; Ross, R.P.; Fitzgerald, G.F.; Collins, J.K.; Wallace, J.M.; Stanton, C. Influence of two commercially available bifidobacteria cultures on Cheddar cheese quality. Int. Dairy J. 2001, 11, 599–610.
53. Haynes, I.N.; Playne, M.J. Survival of probiotic cultures in low-fat ice-cream. Aust. J. Dairy Technol. 2002, 57, 10–14.
54. Davidson, R.H.; Duncan, S.E.; Hackney, C.R.; Eigel, W.N.; Boling, J.W. Probiotic culture survival and implications in fermented frozen yogurt characteristics. J. Dairy Sci. 2000, 83, 666–673.
55. Rodgers, S.; Odongo, R. Survival of Lactobacillus acidophilus, L. casei and Bifidobacterium lactis in coleslaw during refrigerated storage. Food Aust. 2002, 54, 185–188.
56. Charteris, W.P.; Kelly, P.M.; Morelli, L.; Collins, J.K. Edible table (bio)spread containing potentially probiotic Lactobacillus and Bifidobacterium species. Int. J. Dairy Technol. 2002, 55, 44–56.
57. Pidcock, K.; Heard, G.M.; Henriksson, A. Application of nontraditional meat starter cultures in production of Hungarian salami. Int. J. Food. Microbiol. 2002, 76, 75–81.
58. Park, J.H.; Um, J.I.; Lee, B.J.; Goh, J.S.; Park, S.Y.; Kim, W.S.; Kim, P.H. Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production. Cell. Immunol. 2002, 219, 22–27.
59. Shah, N.P.; Ravula, R.R. Microencapsulation of probiotic bacteria and their survival in frozen fermented dairy desserts. Aust. J. Dairy Technol. 2000, 55, 139–144.
60. Sultana, K.; Godward, G.; Reynolds, N.; Arumugaswamy, R.; Peiris, P.; Kailasapathy, K. Encapsulation of probiotic bacteria with alginate-starch and evaluation of survival in simulated gastrointestinal conditions and in yoghurt. Int. J. Food Microbiol. 2000, 62, 47–55.
61. Cui, J.H.; Goh, J.S.; Kim, P.H.; Choi, S.H.; Lee, B.J. Survival and stability of bifidobacteria loaded in alginate poly-l-lysine microparticles. Int. J. Pharm. 2000, 210, 51–59.
62. Fávaro Trindade, C.S.; Grosso, C.R.F. The effect of the immobilisation of Lactobacillus acidophilus and Bifidobacterium lactis in alginate on their tolerance to gastrointestinal secretions. Milchwissenschaft 2000, 55, 496–499.
63. Lee, K.Y.; Heo, T.R. Survival of Bifidobacterium longum immobilized in calcium alginate beads in simulated gastric juices and bile salt solution. Appl. Environ. Microbiol. 2000, 66, 869–873.
64. Cui, J.H.; Goh, J.S.; Park, S.Y.; Kim, P.H.; Lee, B.J. Preparation and physical characterization of alginate microparticles using air atomization method. Drug Dev. Indust. Pharm. 2001, 27, 309–319.
65. Hansen, L.T.; Allan-Wojtas, P.M.; Jin, Y.L.; Paulson, A.T. Survival of Ca-alginate microencapsulated Bifidobacterium spp. in milk and simulated gastrointestinal conditions. Food Microbiol. 2002, 19, 35–45.
66. Adhikari, K.; Mustapha, A.; Grun, I.U.; Fernando, L. Viability of microencapsulated bifidobacteria in set yogurt during refrigerated storage. J. Dairy Sci. 2000, 83, 1946–1951.
67. Adhikari, K.; Mustapha, A.; Grun, I.U. Survival and metabolic activity of microencapsulated Bifidobacterium longum in stirred yogurt. J. Food Sci. 2003, 68, 275–280.
68. O’Riordan, K.; Andrews, D.; Buckle, K.; Conway, P. Evaluation of microencapsulation of a Bifidobacterium strain with starch as an approach to prolonging viability during storage. J. Appl. Microbiol. 2001, 91, 1059–1066.
69. Sun, W.R.; Griffiths, M.W. Survival of bifidobacteria in yogurt and simulated gastric juice following immobilization in gellan-xanthan beads. Int. J. Food Microbiol. 2000, 61, 17–25.
70. Fávaro Trindale, C.S.; Grosso, C.R.F. Microencapsulation of L. acidophilus (La-05) and B. lactis (Bb-12) and evaluation of their survival at the pH values of the stomach and in bile. J. Microencapsulation 2002, 19, 485–494.
71. Schmidt, G.; Zink, R. Basic features of the stress response in three species of bifidobacteria: B. longum, B. adolescentis, and B. breve. Int. J. Food Microbiol. 2000, 55, 41–45.
72. Mahalakshmi, R.; Murthy, V.V.P.S. Growth of Bifidobacterium bifidum in whey-based media. J. Industrial Microbiol. Biotechnol. 2000, 25, 177–179.
73. Vijaya, G.V.; Gireesh, T.; Bhat, G.S. Effect of enzymatic hydrolysis of proteins on growth of Bifidobacterium bifidus in milk. J. Sci. Food Agric. 2002, 82, 493–496.
74. Azuma, Y.; Sato, M. Stimulative effect of Lactobacillus gasseriNY0509 and Lactobacillus casei NY1301 on the growth of bifidobacteria. J. Jpn Soc. Food Sci. Technol. 2001, 48, 688–692.
75. Warminska-Radyko, I.; Laniewska-Moroz, L.; Babuchowski, A. Possibilities for stimulation of Bifidobacterium growth by propionibacteria. Lait 2002, 82, 113–121.
76. Lian, W.C.; Hsiao, H.C.; Chou, C.C. Survival of bifidobacteria after spray-drying. Int. J. Food Microbiol. 2002, 74, 79–86.
77. Crittenden, R.G.; Martinez, N.R.; Playne, M.J. Production and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int. J. Food Microbiol. 2003, 80, 217–222.
78. Lamoureux, L.; Roy, D.; Gauthier, S.F. Production of oligosaccharides in yogurt containing bifidobacteria and yogurt cultures. J. Dairy Sci. 2002, 85, 1058–1069.
79. Coakley, M.; Ross, R.P.; Nordgren, M.; Fitzgerald, G.; Devery, R.; Stanton, C. Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species. J. Appl. Microbiol. 2003, 94, 138–145.
80. Tannock, G.W. Analysis of the intestinal microflora using molecular methods. Eur. J. Clin. Nutr. 2002, 56 (Suppl 4), S44–S49.
81. Vaughan, E.E.; de Vries, M.C.; Zoetendal, E.G.; Ben-Amor, K.; Akkermans, A.D.L.; de Vos, W.M. The intestinal LABs. Antonie van Leeuwenhoek Int. J. Gen. Mol. Microbiol. 2002, 82, 341–352.
82. McCartney, A.L.; Wenzhi, W.; Tannock, G.W. Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans. Appl. Environ. Microbiol. 1996, 62, 4608–4613.
83. Kimura, K.; McCartney, A.L.; McConnell, M.A.; Tannock, G.W. Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Appl. Environ. Microbiol. 1997, 63, 3394–3398.
84. Tannock, G.W. Molecular assessment of intestinal microflora. Am. J. Clin. Nutr. 2001, 73, 410S–414S.
85. Mangin, I.; Bouhnik, Y.; Bisetti, N.; Decaris, B. Molecular monitoring of human intestinal Bifidobacterium strain diversity. Res. Microbiol. 1999, 150, 343–350.
86. McCartney, A.L. Application of molecular biological methods for studying probiotics and the gut flora. Br. J. Nutr. 2002, 88 (Suppl 1), S29–S37.
87. Mackie, R.I.; Sghir, A.; Gaskins, H.R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 1999, 69, 1035S–1045S.
88. Tannock, G.W. The bifidobacterial and lactobacillus microflora of humans. Clin. Rev. Allergy Immunol. 2002, 22, 231–253.
89. Satokari, R.M.; Vaughan, E.E.; Akkerman, A.D.L.; Saarela, M.; de Vos, W.M. Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 2001, 67, 504–513.
90. Marteau, P.; Pochart, P.; Dore, J.; Bera-Maillet, C.; Bernalier, A.; Corthier, G. Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl. Environ. Microbiol. 2001, 67, 4939–4942.
91. Franks, A.H.; Harmsen, H.J.; Raangs, G.C.; Jansen, G.J.; Schut, F.; Welling, G.W. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol. 1998, 64, 3336–3345.
92. Sghir, A.; Gramet, G.; Suau, A.; Rochet, V.; Pochart, P.; Dore, J. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl. Environ. Microbiol. 2000, 66, 2263–2266.
93. Harmsen, H.J.; Wildeboer-Veloo, A.C.; Grijpstra, J.; Knol, J.; Degener, J.E.; Welling, G.W. Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl. Environ. Microbiol. 2000, 66, 4523–4527.
94. Requena, T.; Burton, J.; Matsuki, T.; Munro, K.; Simon, M.A.; Tanaka, R.; Watanabe, K.; Tannock, G.W. Identification, detection, and enumeration of human Bifidobacterium species by PCR targeting the transaldolase gene. Appl. Environ. Microbiol. 2002, 68, 2420–2427.
95. Ouwehand, A.C.; Isolauri, E.; Kirjavainen, R.V.; Salminen, S.J. Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol. Lett. 1999, 172, 61–64.
96. He, F.; Ouwehand, A.C.; Isolauri, E.; Hosoda, M.; Benno, Y.; Salminen, S. Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. Curr. Microbiol. 2001, 43, 351–354.
97. He, F.; Ouwehand, A.C.; Hashimoto, H.; Isolauri, E.; Benno, Y.; Salminen, S. Adhesion of Bifidobacterium spp. to human intestinal mucus. Microbiol. Immunol. 2001, 45, 259–262.
98. He, F.; Ouwehand, A.C.; Isolauri, E.; Hashimoto, H.; Benno, Y.; Salminen, S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol. Med. Microbiol. 2001, 30, 43–47.
99. MacFarlane, S.; Hopkins, M.J.; Macfarlane, G.T. Bacterial growth and metabolism on surfaces in the large intestine. Microbial Ecol. Health Dis. 2000, 12, 64–72.
100. Crittenden, R.; Laitila, A.; Forssell, P.; Mättö, J.; Saarela, M.; Mattila-Sandholm, T.; Myllärinen, P. Adhesion of bifidobacteria to granular starch and its implications in probiotic technologies. Appl. Environ. Microbiol. 2001, 67, 3469–3475.
101. Harmsen, H.J.M.; Wildeboer-Veloo, A.C.M.; Raangs, G.C.; Wagendorp, A.A.; Klijn, N.; Bindels, J.G.; Welling, G.W. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 2000, 30, 61–67.
102. Matsuki, T.; Watanabe, K.; Tanaka, R.; Fukuda, M.; Oyaizu, H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted speciesspecific primers. Appl. Environ. Microbiol. 1999, 65, 4506–4512.
103. Saito, Y.; Hamanaka, Y.; Saito, K.; Takizawa, S.; Benno, Y. Stability of species composition of fecal bifidobacteria in human subjects during fermented milk administration. Curr. Microbiol. 2002, 44, 368–373.
104. Ventura, M.; Elli, M.; Reniero, R.; Zink, R. Molecular microbial analysis of Bifidobacterium isolates from different environments by the species-specific amplified ribosomal DNA restriction analysis (ARDRA). FEMS Microbiol. Ecol. 2001, 36, 113–121.
105. Hopkins, M.J.; Sharp, R.; Macfarlane, G.T. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001, 48, 198–205.
106. Hopkins, M.J.; Sharp, R.; Macfarlane, G.T. Variation in human intestinal microbiota with age. Dig. Liver. Dis. 2002, 34 (Suppl 2), S12–S18.
107. Canzi, E.; Casiraghi, M.C.; Zanchi, R.; Gandolfi, R.; Ferrari, A.; Brighenti, F.; Bosia, R.; Crippa, A.; Maestri, P.; Vesely, R.; Salvadori, B.B. Yogurt in the diet of the elderly: a preliminary investigation into its effect on the gut ecosystem and lipid metabolism. Lait 2002, 82, 713–723.
108. Silvi, S.; Verdenelli, M.C.; Orpianesi, C.; Cresci, A. EU project Crownalife: functional foods, gut microflora and healthy ageing—isolation and identification of Lactobacillus and Bifidobacterium strains from faecal samples of elderly subjects for a possible probiotic use in functional foods. J. Food Eng. 2003, 56, 195–200.
109. Zoetendal, E.G.; Akkermans, A.D.; de Vos, W.M. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl. Environ. Microbiol. 1998, 64, 3854–3859.
110. Tannock, G.W. A fresh look at faeces. Microbiol. Aust. 2003, 24, 34–35.
111. Moro, G.; Minoli, I.; Mosca, M.; Fanaro, S.; Jelinek, J.; Stahl, B.; Boehm, G. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J. Pediatr. Gastroenterol. Nutr. 2002, 34, 291–295.
112. Crittenden, R.G. Prebiotics. In: Probitoics: A Critical Review; Tannock, G.W., Ed.; Horizon Scientific Press: Wymondham, 1999; 141–156.
113. Gibson, G.R.; Roberfroid, M.B. Dietary modulation of the human colonic microbiota— introducing the concept of prebiotics. J. Nutr. 1995, 125, 1401–1412.
114. Alander, M.; Mättö, J.; Kneifel, W.; Johansson, M.; Kögler, B.; Crittenden, R.; Mattila- Sandholm, T.; Saarela, M. Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. Int. Dairy J. 2001 11, 917–925.
115. Satokari, R.M.; Vaughan, E.E.; Akkermans, A.D.L.; Saarela, M.; de Vos, W.M. Polymerase chain reaction and denaturing gradient gel electrophoresis monitoring of fecal Bifido-bacterium populations in a prebiotic and probiotic feeding trial. Syst. Appl. Microbiol. 2001, 24, 227–231.
116. Malinen, E.; Mättö, J.; Salmitie, M.; Alander, M.; Saarela, M.; Palva, A. PCR-ELISA-II: analysis of Bifidobacterium populations in human faecal samples from a consumption trial with Bifidobacterium lactis Bb-12 and a galacto-oligosaccharide preparation. Syst. Appl. Microbiol. 2002, 25, 249–258.
117. Crittenden, R.; Karppinen, S.; Ojanen, S.; Tenkanen, M.; Fagerström, R.; Mättö, J.; Saarela, M.; Mattila-Sandholm, T.; Poutanen, K. In vitro fermentation of cereal dietary fibre carbohydrates by probiotic and intestinal bacteria. J. Sci. Food Agric. 2002, 82, 1–9.
118. Björkstén, B.; Naaber, P.; Sepp, E.; Mikelsaar, M. The intestinal microflora in allergic Estonian and Swedish 2-year old children. Clin. Exp. Allergy 1999, 29, 342–346.
119. Björkstén, B.; Sepp, E.; Julge, K.; Voor, T.; Mikelsaar, M. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 2001, 108, 516–520.
120. Böttcher, M.; Sandin, A.; Norin, E.; Midtvedt, T.; Björkstén, B. Microflora associated characteristics in faeces from allergic and non-allergic children. Clin. Exp. Allergy 2000, 30, 590–596.
121. Grönlund, M.M.; Arvilommi, H.; Kero, P.; Lehtonen, O.P.; Isolauri, E. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0–6 months. Arch. Dis. Child. 2000, 83, F186–F192.
122. Kalliomäki, M.; Kirjavainen, P.; Eerola, E.; Kero, P.; Salminen, S.; Isolauri, E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 2001, 107, 129–134.
123. Kirjavainen, P.V.; Apostolou, E.; Arvola, T.; Salminen, S.J.; Gibson, G.R.; Isolauri, E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol. Med. Microbiol. 2001, 32, 1–7.
124. Kirjavainen, P.V.; Arvola, T.; Salminen, S.J.; Isolauri, E. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 2002, 51, 51–55.
125. Ouwehand, A.C.; Isolauri, E.; He, F.; Hashimoto, H.; Benno, Y.; Salminen, S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J. Allergy Clin. Immunol. 2001, 108, 144–145.
126. Apostolou, E.; Pelto, L.; Kirjavainen, P.V.; Isolauri, E.; Salminen, S.J.; Gibson, G.R. Differences in the gut bacterial flora of healthy and milk-hypersensitive adults, as measured by fluorescence in situ hybridisation. FEMS Immunol. Med. Microbiol. 2001, 30, 217–221.
127. Linskens, R.K.; Huijsdens, X.W.; Savelkoul, P.H.M.; Vandenbroucke-Grauls, C.M.J.E.; Meuwissen, S.M.G. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand. J. Gastroenterol. 2001, 36, S29–S40.
128. Madden, J.A.J.; Hunter, J.O. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br. J. Nutr. 2002, 88, S67–S72.
129. Hopkins, M.J.; MacFarlane, G.T. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J. Med. Microbiol. 2002, 51, 448–454.
130. Hayashi, H.; Sakamoto, M.; Benno, Y. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol. Immunol. 2002, 46, 535–548.
131. Matsuki, T.; Watanabe, K.; Fujimoto, J.; Miyamoto, Y.; Takada, T.; Matsumoto, K.; Oyaizu, H.; Tanaka, R. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl. Environ. Microbiol. 2002, 68, 5445–5451.
132. Wickens, K.; Pearce, N.; Crane, J.; Beasley, R. Antibiotic use in early childhood and the development of asthma. Clin. Exp. Allergy 1999, 29, 766–771.
133. Fujiwara, S.; Seto, Y.; Kimura, A.; Hashiba, H. Intestinal transit of an orally administered streptomycin-rifampicin-resistant variant of Bifidobacterium longum SBT2928: its longterm survival and effect on the intestinal microflora and metabolism. J. Appl. Microbiol. 2001, 90, 43–52.
134. Germond, J.E.; Mamin, O.; Mollet, B. Species specific identification of nine human Bifidobacterium spp. in feces. Syst. Appl. Microbiol. 2002, 25, 536–543.
135. Klaenhammer, T.; Altermann, E.; Arigoni, F.; Bolotin, A.; Breidt, F.; Broadbent, J.; Cano, R.; Chaillou, S.; Deutscher, J.; Gasson, M.; van de Guchte, M.; Guzzo, J.; Hartke, A.; Hawkins, T.; Hols, P.; Hutkins, R.; Kleerebezem, M.; Kok, J.; Kuipers, O.; Lubbers, M.; Maguin, E.; McKay, L.; Mills, D.; Nauta, A.; Overbeek, R.; Pel, H.; Pridmore, D.; Saier, M.; van Sinderen, D.; Sorokin, A.; Steele, J.; O’Sullivan, D.; de Vos, W.; Weimer, B.; Zagorec, M.; Siezen, R. Discovering lactic acid bacteria by genomics. Antonie van Leeuwnhoek Int. J. Gen. Mol. Microbiol. 2002, 82, 29–58.
136. Schell, M.A.; Karmirantzou, M.; Snel, B.; Vilanova, D.; Berger, B.; Pessi, G.; Zwahlen, M.C.; Desiere, F.; Bork, P.; Delley, M.; Pridmore, R.D.; Arigoni, F. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc. Nat. Acad. Sci. USA 2002, 99, 14422–14427.
137. Mack, D.R.; Michail, S.; Wei, S.; McDougall, L.; Hollingsworth, M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 1999, 276, G941–G950.
138. Mattar, A.; Teitelbaum, D.H.; Drongowski, R.A.; Yongyi, F.; Harmon, C.M.; Coran, A.G. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr. Surg. Int. 2002, 18, 586–590.
139. Cummings, J.H.; Macfarlane, G.T. Gastrointestinal effects of prebiotics. Br. J. Nutr. 2002, 87, S145–S151.
140. Guigoz, Y.; Rochat, F.; Perruisseau-Carrier, G.; Rochat, I.; Schiffrin, E.J. Effects of oligosaccharide on the faecal flora and non-specific immune system in elderly people. Nutr. Res. 2002, 22, 13–25.
141. Hung, M.N.; Lee, B.H. Purification and characterization of a recombinant beta-galactosidase with transgalactosylation activity from Bifidobacterium infantis HL96. Appl. Microbiol. Biotechnol. 2002, 58, 439–445.
142. Jorgensen, F.; Hansen, O.C.; Stougaard, P. High-efficiency synthesis of oligosaccharides with a truncated beta-galactosidase from Bifidobacterium bifidum. Appl. Microbiol. Biotechnol. 2001, 57, 647–652.
143. Hopkins, M.J.; Cummings, J.H.; Macfarlane, G.T. Inter-species differences in maximum specific growth rates and cell yields of bifidobacteria cultured on oligosaccharides and other simple carbohydrate sources. J. Appl. Microbiol. 1998, 85, 381–386.
144. Brigidi, P.; Swennen, E.; Vitali, B.; Rossi, M.; Matteuzzi, D. PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption. Int. J. Food Microbiol. 2003, 81, 203–209.
145. Isolauri, E. Immune effects of probiotics. In: Probiotics, Other Nutritional Factors, and Intestinal Microflora; Hanson, L.A., Yolken, R.H., Eds.; Lippincott-Raven Publishers: Philadelphia, 1999; 229–241.
146. Saavedra, J.M.; Tschernia, A. Human studies with probiotics and prebiotics: clinical implications. Br. J. Nutr. 2002, 87 (Suppl 2), S241–S246.
147. Kalliomäki, M.; Salminen, S.; Arvilommi, H.; Kero, P.; Koskinen, P.; Isolauri, E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001, 357, 1076–1079.
148. Sartor, R.B. Induction of mucosal immune responses by bacteria and bacterial components. Curr. Opin. Gastroenterol. 2001, 17, 555–561.
149. Prescott, S.L.; Macaubas, C.; Smallacombe, T.; Hol, B.J.; Sly, P.D.; Holt, P.G. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999, 353, 196–200.
150. Holt, P.G.; Sly, P.D.; Björkstén, B. Atopic versus infectious diseases in childhood: a question of balance? Pediatr. Allergy Immunol. 1998, 8, 53–58.
151. Hessle, C.; Andersson, B.; Wold, A.E. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect. Immun. 2000, 68, 3581–3586.
152. Schiffrin, E.J.; Blum, S. Interactions between the microbiota and the intestinal mucosa. Eur. J. Clin. Nutr. 2002, 56 (Suppl 3), S60–S64.
153. Karlsson, H.; Hessle, C.; Rudin, A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect. Immun. 2002, 70, 6688–6696.
154. He, F.; Morita, H.; Ouwehand, A.C.; Hosoda, M.; Hiramatsu, M.; Kurisaki, J.; Isolauri, E.; Benno, Y.; Salminen, S. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol. Immunol. 2002, 46, 781–785.
155. He, F.; Morita, H.; Hashimoto, H.; Hosoda, M.; Kurisaki, J.I.; Ouwehand, A.C.; Isolauri, E.; Benno, Y.; Salminen, S. Intestinal Bifidobacterium species induce varying cytokine production. J. Allergy Clin. Immunol. 2002, 109, 1035–1036.
156. Pelto, L.; Laitinen, I.; Lilius, E-M. Current perspectives on milk hypersensitivity. Trends Food Sci. Technol. 1999, 10, 229–233.
157. Pelto, L.; Impivaara, O.; Salminen, S.; Poussa, T.; Seppänen, R.; Lilius, E-M. Milk hypersensitivity in young adults. Eur. J. Clin. Nutr. 1999, 53, 620–624.
158. Woods, R.K.; Thien, F.; Raven, J.; Walters, A.H.; Abramson, M.A. Prevalence of food allergies in young adults and their relationship to asthma, nasal allergies, and eczema. Ann. Allergy Asthma. Immunol. 2002, 88, 183–189.
159. Aldinucci, C.; Bellussi, L.; Monciatti, G.; Passali, G.C.; Salerni, L.; Passali, D.; Bocci, V. Effects of dietary yoghurt on immunological and clinical parameters of rhinopathic patients. Eur. J. Clin. Nutr. 2002, 56, 1155–1161.
160. Perdigón, G.; Galdeano, C.M.; Valdez, J.C.; Medici, M. Interaction of lactic acid bacteria with the gut immune system. Eur. J. Clin. Nutr. 2002, 56 (Suppl 4), S21–S26.
161. Shciffrin, E.J.; Brassart, D.; Servin, A.L.; Rochart, F.; Donnet-Hughes, A. Immune modulation of blood leucocytes in humans by lactic acid bacteria: criteria for strain selection. Am. J. Clin. Nutr. 1997, 66, S515–S5120.
162. Shu, Q.; Gill, H.S. A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice. Med. Microbiol. Immunol. 2001, 189, 147–152.
163. Qiao, H.P.; Duffy, L.C.; Griffiths, E.; Dryja, D.; Leavens, A.; Rossman, J.; Rich, G.; Riepenhoff-Talty, M.; Locniskar, M. Immune responses in rhesus rotavirus-challenged balb/c mice treated with bifidobacteria and prebiotic supplements. Pediatr. Res. 2002, 51, 750–755.
164. Araki, T.; Shinozaki, T.; Irie, Y.; Miyazawa, Y. Trial of oral administration of Bifidobacterium breve for the prevention of rotavirus infection. J. Jpn Assoc. Infect. Dis. 1999, 73, 305–310.
165. Gill, H.S.; Rutherfurd, K.J.; Prasad, J.; Gopal, P.K. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr. 2000, 83, 167–176.
166. Shu, Q.; Qu, F.; Gill, H.S. Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J. Pediatr. Gastroenterol. Nutr. 2001, 33, 171–177.
167. Yasui, H.; Kiyoshima, J.; Hori, T.; Shida, K. Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064. Clin. Diagn. Lab. Immunol. 1999, 6, 186–192.
168. Morita, H.; He, F.; Fuse, T.; Ouwehand, A.C.; Hashimoto, H.; Hosoda, M.; Mizumachi, K.; Kurisaki, J.I. Adhesion of lactic acid bacteria to Caco-2 cells and their effect on cytokine secretion. Microbiol. Immunol. 2002, 46, 293–297.
169. Van Neil, C.W.; Feudtner, C.; Garrison, M.M.; Christakis, D.A. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002, 109, 678–682.
170. Shu, Q.; Lin, H.; Rutherfurd, K.J.; Fenwick, S.G.; Prasad, J.; Gopal, P.K.; Gill, H.S. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice. Microbiol. Immunol. 2000, 44, 213–222.
171. Kim, S.H.; Yang, S.J.; Koo, R.C.; Bae, W.K.; Kim, J.Y.; Park, J.H.; Baek, Y.J.; Park, Y.H. Inhibitory activity of Bifidobacterium longum HY8001 against vero cytotoxin of Escherichia coli O157:H7. J. Food Prot. 2001, 64, 1667–1673.
172. Khedkar, J.N.; Dave, J.M.; Sannabhadti, S.S. Antibacterial activity associated with Bifidobacterium adolescentis. J. Food Sci. Technol. 1998, 35, 527–529.
173. Lievin, V.; Peiffer, I.; Hudault, S.; Rochat, F.; Brassart, D.; Neeser, J.R.; Servin, A.L. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 2000, 47, 646–652.
174. Henriksson, A.; Conway, P.L. Isolation of human faecal bifidobacteria which reduce signs of Salmonella infection when orogastrically dosed to mice. J. Appl. Microbiol. 2001, 90, 223–228.
175. Bruno, F.A.; Shah, N.P. Inhibition of pathogenic and putrefactive microorganisms by Bifidobacterium sp. Milchwissenschaft. 2002, 57, 617–621.
176. Gopal, P.K.; Prasad, J.; Smart, J.; Gill, H.S. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int. J. Food Microbiol. 2001, 67, 207–216.
177. Yusof, R.M.; Haque, F.; Ismail, M.; Hassan, Z. Isolation of Bifidobacterium infantis and its antagonistic activity against ETEC 0157 and Salmonella typhimurium S-285 in weaning foods. Asia Pacific J. Clin. Nutr. 2000, 9, 130–135.
178. Asahara, T.; Nomoto, K.; Shimizu, K.; Watanuki, M.; Tanaka, R. Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides. J. Appl. Microbiol. 2001, 91, 985–996.
179. Fujiwara, S.; Hashiba, H.; Hirota, T.; Forstner, J.F. Purification and characterization of a novel protein produced by Bifidobacterium longum SBT2928 that inhibits the binding of enterotoxigenic Escherichia coli Pb176 (CFA/II) to gangliotetraosylceramide. J. Appl. Microbiol. 1999, 86, 615–621.
180. Fujiwara, S.; Hashiba, H.; Hirota, T.; Forstner, J.F. Inhibition of the binding of enterotoxigenic Escherichia coli Pb176 to human intestinal epithelial cell line HCT-8 by an extracellular protein fraction containing BIF of Bifidobacterium longum SBT2928: suggestive evidence of blocking of the binding receptor gangliotetraosylceramide on the cell surface. Int. J. Food Microbiol. 2001, 67, 97–106.
181. Zoppi, G.; Cinquetti, M.; Benini, A.; Bonamini, E.; Minelli, E.B. Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone. Curr. Ther. Res. Clin. Exp. 2001, 62, 418–435.
182. Caplan, M.S.; Miller-Catchpole, R.; Kaup, S.; Russell, T.; Lickerman, M.; Amer, M.; Xiao, Y.; Thomson, R. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 1999, 117, 577–583.
183. Silva, A.M.; Bambirra, E.A.; Oliveira, A.L.; Souza, P.P.; Gomes, D.A.; Vieira, E.C.; Nicoli, J.R. Protective effect of bifidus milk on the experimental infection with Salmonella enteritidis subsp. typhimurium in conventional and gnotobiotic mice. J. Appl. Microbiol. 1999, 86, 331–336.
184. Bibiloni, R.; Fernando, P.; De Antoni, G.L. Will a high adhering capacity in a probiotic strain guarantee exclusion of pathogens from intestinal epithelia. Anaerobe 1999, 5, 519–524.
185. Eizaguirre, I.; Urkia, N.G.; Asensio, A.B.; Zubillaga, I.; Zubillaga, P.; Vidales, C.; Garcia- Arenzana, J.M.; Aldazabal, P. Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome. J. Pediatr. Surg. 2002, 37, 699–702.
186. Marteau, P.R. Probiotics in clinical conditions. Clin. Rev. Allergy Immunol. 2002, 22, 255–273.
187. Reddy, B.S. Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. J. Nutr. 1999, 129, 1478S–1482S.
188. Rafter, J. Lactic acid bacteria and cancer: mechanistic perspective. Br. J. Nutr. 2002, 88 (Suppl 1), S89–S94.
189. Matsumoto, M.; Ohishi, H.; Benno, Y. Impact of LKM512 yogurt on improvement of intestinal environment of the elderly. FEMS Immunol. Med. Microbiol. 2001, 31, 181–186.
190. Tavan, E.; Cayuela, C.; Antoine, J.M.; Cassand, P. Antimutagenic activities of various lactic acid bacteria against food mutagens: heterocyclic amines. J. Dairy Res. 2002, 69, 335–341.
191. Lo, P.R.; Yu, R.C.; Chou, C.C.; Tsai, Y.H. Antimutagenic activity of several probiotic bifidobacteria against benzo[a]pyrene. J. Biosci. Bioeng. 2002, 94, 148–153.
192. Gallaher, D.D.; Khil, J. The effect of synbiotics on colon carcinogenesis in rats. J. Nutr. 1999, 129, 1483S–1487S.
193. Bolognani, F.; Rumney, J.C.; Pool-Zobel, B.L.; Rowland, I.R. Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur. J. Nutr. 2001, 40, 293–300.
194. Femia, A.P.; Luceri, C.; Dolara, P.; Giannini, A.; Biggeri, A.; Salvadori, M.; Clune, Y.; Collins, J.K.; Paglierani, M.; Caderni, G. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002, 23, 1953–1960.
195. Yazawa, K.; Fujimori, M.; Amano, J.; Kano, Y.; Taniguchi, S. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther. 2000, 7, 269–274.
196. Yazawa, K.; Fujimori, M.; Nakamura, T.; Sasaki, T.; Amano, J.; Kano, Y.; Taniguchi, S. Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Res. Treatment 2001, 66, 165–170.
197. Nakamura, T.; Sasaki, T.; Fujimori, M.; Yazawa, K.; Kano, Y.; Amano, J.; Taniguchi, S. Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors. Biosci. Biotechnol. Biochem. 2002, 66, 2362–2366.
198. Li, X.; Fu, G.F.; Fan, Y.R.; Liu, W.H.; Liu, X.J.; Wang, J.J.; Xu, G.X. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther. 2003, 10, 105–111.